Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.922
+0.024 (2.66%)
At close: Apr 28, 2026, 4:00 PM EDT
0.940
+0.018 (1.91%)
After-hours: Apr 28, 2026, 7:02 PM EDT
Standard BioTools Employees
As of December 31, 2025, Standard BioTools had 389 total employees, including 385 full-time and 4 part-time employees. The number of employees decreased by 429 or -52.44% compared to the previous year.
Employees
389
Change (1Y)
-429
Growth (1Y)
-52.44%
Revenue / Employee
$219,360
Profits / Employee
-$192,535
Market Cap
359.80M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Viemed Healthcare | 1,382 |
| OrthoPediatrics | 602 |
| Pacific Biosciences of California | 485 |
| RxSight | 461 |
| Cerus | 275 |
| ClearPoint Neuro | 172 |
| Profound Medical | 162 |
| Delcath Systems | 156 |
LAB News
- 2 months ago - Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewsWire
- 3 months ago - Standard BioTools Completes Sale of SomaLogic to Illumina - GlobeNewsWire
- 3 months ago - Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue - GlobeNewsWire
- 5 months ago - Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry - Business Wire
- 6 months ago - Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks - PRNewsWire
- 6 months ago - Standard BioTools Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 months ago - Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025 - GlobeNewsWire